Stem, Inc. (STEM) has disclosed a new risk, in the Corporate Activity and Growth category. Stem, Inc. faces significant risks in its attempts to ...

Stem (NYSE:STEM) experienced a significant 14.32% increase in total shareholder returns over the last quarter. This move can be partially attributed to leadership changes, including the appointment of ...

Roth Mkm’s price objective points to a potential downside of 9.71% from the stock’s previous close. STEM has been the topic of a number of other research reports. Piper Sandler reduced their ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial.

Try Now>> See the top stocks recommended by analysts >> Read More on STEM: Related Stocks Indices Commodities Currencies Stocks ...

$STEM ($STEM) is expected to release its quarterly earnings data on Tuesday, March 4th after market close, per Finnhub. Analysts are expecting revenue of $48,842,404 ...